GSK Lags Q4 Earnings, Tops Sales, Issues Upbeat '24 Guidance
https://www.zacks.com/stock/news/2218970/gsk-lags-q4-earnings-tops-sales-issues-upbeat-24-guidance?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2218970
Jan 31, 2024 - GSK's revenues benefit from strong growth across all segments, especially the Shingles and RSV vaccines. The company also issues fresh 2024 guidance for all its segments.
0
Why Marriott International (MAR) is a Top Growth Stock for the Long-Term
https://www.zacks.com/stock/news/2218710/why-marriott-international-mar-is-a-top-growth-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_growth_score-2218710
Jan 31, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
0
Why The Bank of New York Mellon Corporation (BK) is a Top Value Stock for the Long-Term
https://www.zacks.com/stock/news/2218736/why-the-bank-of-new-york-mellon-corporation-bk-is-a-top-value-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2218736
Jan 31, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
0
Top wealth manager Julius Baer caught in property write-off storm as CEO steps down
https://www.cnbc.com/2024/02/01/julius-baer-hit-by-signa-exposure-announces-ceo-exit-and-job-cuts.html
Feb 01, 2024 - The company will cut 250 jobs this year, impacting around 3% of its 7,425 employees.
0
Merck results beat expectations as top drugs Keytruda, Gardasil post strong sales
https://www.cnbc.com/2024/02/01/merck-mrk-q4-earnings-report-2023.html
Feb 01, 2024 - Merck still posted a quarterly loss due to previously announced charges associated with its cancer drug collaboration deal with Daiichi Sankyo.
0
Core Laboratories beats top-line and bottom-line estimates; initiates Q124 outlook
https://seekingalpha.com/news/4061030-core-laboratories-beats-top-line-and-bottom-line-estimates-initiates-q124-outlook?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
Jan 31, 2024 - Core Laboratories beats earnings estimates in Q4 2023, reporting Non-GAAP EPS of $0.19, surpassing expectations by $0.01, with revenue of $128.2M, beating...
0
MGIC Investment (MTG) Q4 Earnings Top Estimates, Revenues Lag
https://www.zacks.com/stock/news/2219653/mgic-investment-mtg-q4-earnings-top-estimates-revenues-lag?cid=CS-ZC-FT-analyst_blog|earnings_article-2219653
Feb 01, 2024 - MGIC Investment's (MTG) fourth-quarter results gain from higher net investment income and lower underwriting and other expenses. Lower net premiums written partially offset the positives.
0
Amazon (AMZN) Tops Q4 Earnings and Revenue Estimates
https://www.zacks.com/stock/news/2219838/amazon-amzn-tops-q4-earnings-and-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2219838
Feb 01, 2024 - Amazon (AMZN) delivered earnings and revenue surprises of 24.69% and 2.23%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
0
Clearfield (CLFD) Reports Q1 Loss, Tops Revenue Estimates
https://www.zacks.com/stock/news/2219830/clearfield-clfd-reports-q1-loss-tops-revenue-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2219830
Feb 01, 2024 - Clearfield (CLFD) delivered earnings and revenue surprises of 12.50% and 13.72%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
0
Top Stocks to Buy After Earnings in a Week Highlighted by Tech
https://www.zacks.com/commentary/2219817/top-stocks-to-buy-after-earnings-in-a-week-highlighted-by-tech?cid=CS-ZC-FT-investment_ideas-2219817
Feb 01, 2024 - Investors are certainly sifting through winners in this week's busy earnings lineup which featured results from tech giants Alphabet (GOOGL) and Microsoft (MSFT) on Tuesday with Apple (AAPL), Amazon (AMZN), and Meta Platforms (META) set to report after the bell today.
0